| scholarly article | Q13442814 |
| P50 | author | Joachim Grötzinger | Q28322146 |
| Christoph Garbers | Q37838064 | ||
| Samadhi Aparicio-Siegmund | Q47008826 | ||
| Stefan Rose-John | Q47812749 | ||
| Christoph Hölscher | Q91743109 | ||
| P2093 | author name string | Georg H Waetzig | |
| Joachim Grötzinger | |||
| Jürgen Scheller | |||
| Björn Spudy | |||
| Inken Lorenzen | |||
| Jan Sommer | |||
| Samadhi Aparicio-Siegmund | |||
| P2860 | cites work | Signaling of human ciliary neurotrophic factor (CNTF) revisited. The interleukin-6 receptor can serve as an alpha-receptor for CTNF | Q24297991 |
| WSX-1 and glycoprotein 130 constitute a signal-transducing receptor for IL-27 | Q24307411 | ||
| Therapeutic strategies for the clinical blockade of IL-6/gp130 signaling | Q27002391 | ||
| IL-27, a heterodimeric cytokine composed of EBI3 and p28 protein, induces proliferation of naive CD4+ T cells | Q28214882 | ||
| Soluble gp130 is the natural inhibitor of soluble interleukin-6 receptor transsignaling responses | Q28634282 | ||
| A designer hyper interleukin 11 (H11) is a biologically active cytokine. | Q33400335 | ||
| A role for IL-27p28 as an antagonist of gp130-mediated signaling | Q34688139 | ||
| Viral Interleukin-6: Structure, pathophysiology and strategies of neutralization | Q37822972 | ||
| The pro- and anti-inflammatory properties of the cytokine interleukin-6. | Q37836084 | ||
| ADAM17: a molecular switch to control inflammation and tissue regeneration | Q37900757 | ||
| New directions in the basic and translational biology of interleukin-27 | Q37969347 | ||
| Plasticity and cross-talk of interleukin 6-type cytokines | Q38010926 | ||
| Inhibition of classic signaling is a novel function of soluble glycoprotein 130 (sgp130), which is controlled by the ratio of interleukin 6 and soluble interleukin 6 receptor | Q39459586 | ||
| The IL-27 p28 subunit binds cytokine-like factor 1 to form a cytokine regulating NK and T cell activities requiring IL-6R for signaling | Q39771489 | ||
| Interleukin 27 induces differentiation of neural C6-precursor cells into astrocytes. | Q40062244 | ||
| No inhibition of IL-27 signaling by soluble gp130. | Q40479437 | ||
| Soluble receptors for cytokines and growth factors: generation and biological function | Q40656511 | ||
| Unraveling viral interleukin-6 binding to gp130 and activation of STAT-signaling pathways independently of the interleukin-6 receptor | Q41839982 | ||
| Interleukin-30: A novel antiinflammatory cytokine candidate for prevention and treatment of inflammatory cytokine-induced liver injury | Q42007477 | ||
| Dynamics of the gp130 cytokine complex: a model for assembly on the cellular membrane | Q42158045 | ||
| Complex of soluble human IL-6-receptor/IL-6 up-regulates expression of acute-phase proteins | Q42816476 | ||
| Structure-guided optimization of the interleukin-6 trans-signaling antagonist sgp130. | Q51787521 | ||
| Processing of tumour necrosis factor-α precursor by metalloproteinases | Q59059630 | ||
| Apoptosis is a natural stimulus of IL6R shedding and contributes to the proinflammatory trans-signaling function of neutrophils | Q62658841 | ||
| A bioactive designer cytokine for human hematopoietic progenitor cell expansion | Q62658923 | ||
| Interleukin-6 signal transducer gp130 has specific binding sites for different cytokines as determined by antagonistic and agonistic anti-gp130 monoclonal antibodies | Q70911145 | ||
| Anti-gp130 transducer monoclonal antibodies specifically inhibiting ciliary neurotrophic factor, interleukin-6, interleukin-11, leukemia inhibitory factor or oncostatin M | Q71001742 | ||
| WSX-1 is required for the initiation of Th1 responses and resistance to L. major infection | Q74840049 | ||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P1104 | number of pages | 9 | |
| P304 | page(s) | 4346-4354 | |
| P577 | publication date | 2012-12-03 | |
| P1433 | published in | Journal of Biological Chemistry | Q867727 |
| P1476 | title | An interleukin-6 receptor-dependent molecular switch mediates signal transduction of the IL-27 cytokine subunit p28 (IL-30) via a gp130 protein receptor homodimer | |
| P478 | volume | 288 |
| Q39029629 | A review on interleukins: The key manipulators in rheumatoid arthritis |
| Q92478549 | Current Knowledge of the Potential Links between Inflammation and Prostate Cancer |
| Q90113512 | Decoding the Role of Interleukin-30 in the Crosstalk Between Cancer and Myeloid Cells |
| Q54209318 | Differing Outcome of Experimental Autoimmune Encephalitis in Macrophage/Neutrophil- and T Cell-Specific gp130-Deficient Mice |
| Q39158943 | Dual Roles of IL-27 in Cancer Biology and Immunotherapy |
| Q64891223 | Effects of interleukin-6 receptor blockade on allergen-induced airway responses in mild asthmatics. |
| Q38712876 | Epstein-Barr virus-induced gene 3 (EBI3) can mediate IL-6 trans-signaling |
| Q37365279 | Evaluating the potential of IL-27 as a novel therapeutic agent in HIV-1 infection |
| Q28075849 | Expanding Diversity in Molecular Structures and Functions of the IL-6/IL-12 Heterodimeric Cytokine Family |
| Q89550778 | GP130 Cytokines in Breast Cancer and Bone |
| Q96131864 | Glycosaminoglycans bind human IL-27 and regulate its activity |
| Q50045633 | IL-27 - a double agent in the IL-6 family |
| Q38772289 | IL-27 driven upregulation of surface HLA-E expression on monocytes inhibits IFN-γ release by autologous NK cells |
| Q37684639 | IL-27p28 inhibits central nervous system autoimmunity by concurrently antagonizing Th1 and Th17 responses |
| Q92113984 | IL-6 Trans-signaling Controls Liver Regeneration After Partial Hepatectomy |
| Q38433045 | IL-6 as a keystone cytokine in health and disease |
| Q47418947 | IL-6/IL-12 Cytokine Receptor Shuffling of Extra- and Intracellular Domains Reveals Canonical STAT Activation via Synthetic IL-35 and IL-39 Signaling |
| Q90239680 | Impact of Interleukin-27p28 on T and B Cell Responses during Toxoplasmosis |
| Q39003208 | Inhibition of protein kinase II (CK2) prevents induced signal transducer and activator of transcription (STAT) 1/3 and constitutive STAT3 activation. |
| Q55365932 | Interleukin (IL)-6 Inhibits IL-27- and IL-30-Mediated Inflammatory Responses in Human Monocytes. |
| Q57487601 | Interleukin 30 to Interleukin 40 |
| Q27022577 | Interleukin-27 in T cell immunity |
| Q40262253 | Interleukin-30 (IL27p28) alleviates experimental sepsis by modulating cytokine profile in NKT cells |
| Q38775229 | Interleukin-30: A novel microenvironmental hallmark of prostate cancer progression |
| Q40170313 | Interleukin-6 Family Cytokines |
| Q34000295 | Interleukin-6, but not the interleukin-6 receptor plays a role in recovery from dextran sodium sulfate-induced colitis |
| Q88562718 | Interleukin-6: designing specific therapeutics for a complex cytokine |
| Q93111912 | Metformin inhibits IL-6 signaling by decreasing IL-6R expression on multiple myeloma cells |
| Q41017172 | Minimal interleukin 6 (IL-6) receptor stalk composition for IL-6 receptor shedding and IL-6 classic signaling |
| Q91736923 | Recent insights into targeting the IL-6 cytokine family in inflammatory diseases and cancer |
| Q35279724 | Recombinant p35 from bacteria can form Interleukin (IL-)12, but Not IL-35 |
| Q40621223 | Soluble IL-6 Receptor and IL-27 Subunit p28 Protein Complex Mediate the Antiviral Response through the Type III IFN Pathway |
| Q37252579 | Soluble Interleukin-6 Receptor-Mediated Innate Immune Response to DNA and RNA Viruses |
| Q41585247 | Soluble expression and purification of the functional interleukin-30 protein in Escherichia coli |
| Q92318243 | Targeting Interleukin(IL)-30/IL-27p28 signaling in cancer stem-like cells and host environment synergistically inhibits prostate cancer growth and improves survival |
| Q39128764 | The Composite Cytokine p28/Cytokine-Like Factor 1 Sustains B Cell Proliferation and Promotes Plasma Cell Differentiation |
| Q93158307 | The Immunobiology of the Interleukin-12 Family: Room for Discovery |
| Q41847430 | The amino acid exchange R28E in ciliary neurotrophic factor (CNTF) abrogates interleukin-6 receptor-dependent but retains CNTF receptor-dependent signaling via glycoprotein 130 (gp130)/leukemia inhibitory factor receptor (LIFR). |
| Q90068782 | The molecular basis of chaperone-mediated interleukin 23 assembly control |
| Q38725223 | The role of IL-6 in host defence against infections: immunobiology and clinical implications |
| Q38149939 | gp130: a promising drug target for cancer therapy |
Search more.